News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard May 10, 2019 Corporate and finance Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023 Download May 8, 2019 Corporate and finance Novavax Announces Reverse Stock Split of Common Stock Download May 2, 2019 Corporate and finance Novavax Reports First Quarter 2019 Financial Results Download May 1, 2019 RSV Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases Download Apr 25, 2019 Corporate and finance Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019 Download Show 5102550100 per page«1…45464748495051…74»